Vidac Pharma
Jerusalem
About Vidac Pharma
Vidac is a clinical stage innovative biopharmaceutical company dedicated to discovering and developing first-in-class medicines to help people suffering from a range of oncology and dermatology ailments. We at Vidac are passionate about transforming breakthrough science into innovative therapies to address major unmet medical needs. Our breakthrough technology targets the VDAC/HK2 system that is unique to malignant cells. Modulating this target leads to selective apoptosis of cancer cells without affecting the surrounding healthy tissue, thus holds the promise of delivering first-in-class drugs that are both efficacious and well tolerated by patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $9.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2016)
- Website: vidacpharma.com
- Phone: +97225952090
Industries & Categories
Biopharma, Biotechnology, Clinical Trials, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/vidac-pharma-39444 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.